找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Novel Technologies for Vaccine Development; Igor S Lukashevich,Haval Shirwan Book 2014 Springer-Verlag Wien 2014 infectious disease.preven

[复制链接]
查看: 29847|回复: 49
发表于 2025-3-21 19:15:11 | 显示全部楼层 |阅读模式
书目名称Novel Technologies for Vaccine Development
编辑Igor S Lukashevich,Haval Shirwan
视频video
概述Written by selected experts from academia and industry.Gives a broad and translational overview to the topic.Comprehensive volume on viral vector vaccines ?with focus on different cases of vaccine dev
图书封面Titlebook: Novel Technologies for Vaccine Development;  Igor S Lukashevich,Haval Shirwan Book 2014 Springer-Verlag Wien 2014 infectious disease.preven
描述This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development.
出版日期Book 2014
关键词infectious disease; preventive vaccine; therapeutic cancer vaccines; viral vector vaccine; vaccines
版次1
doihttps://doi.org/10.1007/978-3-7091-1818-4
isbn_softcover978-3-7091-1980-8
isbn_ebook978-3-7091-1818-4
copyrightSpringer-Verlag Wien 2014
The information of publication is updating

书目名称Novel Technologies for Vaccine Development影响因子(影响力)




书目名称Novel Technologies for Vaccine Development影响因子(影响力)学科排名




书目名称Novel Technologies for Vaccine Development网络公开度




书目名称Novel Technologies for Vaccine Development网络公开度学科排名




书目名称Novel Technologies for Vaccine Development被引频次




书目名称Novel Technologies for Vaccine Development被引频次学科排名




书目名称Novel Technologies for Vaccine Development年度引用




书目名称Novel Technologies for Vaccine Development年度引用学科排名




书目名称Novel Technologies for Vaccine Development读者反馈




书目名称Novel Technologies for Vaccine Development读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:25:23 | 显示全部楼层
Rajesh K. Sharma,Abhishek K. Srivastava,Hong Zhao,Esma S. Yolcu,Haval Shirwan
发表于 2025-3-22 01:16:48 | 显示全部楼层
发表于 2025-3-22 05:40:06 | 显示全部楼层
Reverse Genetics Approaches for Rational Design of Inactivated and Live Attenuated Influenza Vaccine of influenza viruses from cloned cDNA, which allows the introduction of mutations at will. This technology has been used extensively to develop novel live attenuated vaccine candidates that possess attenuating mutations in one or several viral proteins, elicit cross-protective antibodies, and repli
发表于 2025-3-22 10:24:16 | 显示全部楼层
Viral-Vectored Vaccines to Control Pathogenic Filovirusestive viral-vectored vaccines that have demonstrated efficacy in nonhuman primate models of filoviral hemorrhagic fever, two candidates, one based on a replication-defective adenovirus serotype 5 and the other on a recombinant vesicular stomatitis virus (rVSV), were shown to confer complete protectio
发表于 2025-3-22 15:50:49 | 显示全部楼层
发表于 2025-3-22 19:23:53 | 显示全部楼层
Current Status and Future of Polio Vaccines and Vaccination interruption of virus circulation, vaccination against poliomyelitis will have to continue into the foreseeable future, due to significant differences in the nature and epidemiology of the viruses. This chapter reviews the reasons for the need to maintain high population immunity against poliovirus
发表于 2025-3-22 23:49:22 | 显示全部楼层
Experimental DNA-Launched Live-Attenuated Vaccines Against Infections Caused by Flavi- and Alphaviruion, especially for RNA viruses..Here we describe a novel infectious DNA (iDNA.) vaccine technology which combines advantages of naked DNA vaccination and live-attenuated vaccine efficacy. Using yellow fever 17D vaccine, an experimental IND vaccine TC-83 against Venezuelan equine encephalitis virus
发表于 2025-3-23 03:00:20 | 显示全部楼层
发表于 2025-3-23 05:48:39 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-16 02:30
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表